帕金森病和维生素:关注维生素B12
Arwa Rekik1,2, Carlo Santoro3, Karolina Poplawska-Domaszewicz4,5
1Department of Neurology of Sahloul Hospital, Sousse, Tunisia. arwa.rekik@gmail.com.
Journal of neural transmission (Vienna, Austria : 1996)
|April 11, 2024
概括
维生素B12 (Vit B12) 缺乏可能导致帕金森症,并与帕金森病 (PD) 的进展有关. 补充可能为PD患者提供治疗益处,这需要进一步调查和测试指南.
科学领域:
- 神经学 神经学
- 营养科学 营养科学
背景情况:
- 维生素B12 (Vit B12) 缺乏与神经系统疾病有关,包括帕金森症.
- 关联维生素B12缺乏与帕金森病 (PD) 病理生理学和进展的确切机制仍然不完全理解.
研究的目的:
- 探索维生素B12和PD之间的复杂关系.
- 审查维生素B12在PD中的生理病理学,临床表现和治疗潜力.
主要方法:
- 文献综述侧重于维生素B12,高血糖蛋白和PD之间的相互作用.
- 对研究PD表型,利沃多巴介导的神经病变和维生素B12补充剂的研究进行分析.
主要成果:
- 维生素B12缺乏和高血糖血症与特定的PD表型相关,包括早期的姿势不稳定,跌倒,快速运动进展,认知衰退和自主功能障碍.
- 多神经病是与维生素B12缺乏相关的显著临床特征,特别是在接受注射内利沃多巴治疗的患者中.
结论:
- 维生素B12在神经通路功能中起着至关重要的作用,可能会影响PD的进展.
- 制定维生素B12测试和补充的指导方针对于管理PD患者至关重要.
更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
3.8K
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
